Unlock instant, AI-driven research and patent intelligence for your innovation.

Chimeric gene for improving physiological cyp3a4 expression of cultured human hepatocytes in vitro and construction method thereof

A technology of chimeric gene and in vitro culture, applied in the direction of introducing foreign genetic material using vectors, recombinant DNA technology, DNA/RNA fragments, etc., can solve the problems of not reaching the expression level of primary hepatocytes, and achieve the effect of strong control

Active Publication Date: 2015-09-16
ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although overexpression of related transcription factors can enhance the expression of CYP3A4, it is still far from the expression level of primary hepatocytes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric gene for improving physiological cyp3a4 expression of cultured human hepatocytes in vitro and construction method thereof
  • Chimeric gene for improving physiological cyp3a4 expression of cultured human hepatocytes in vitro and construction method thereof
  • Chimeric gene for improving physiological cyp3a4 expression of cultured human hepatocytes in vitro and construction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Construct recombinant eukaryotic expression vectors PCI-hPXR-P53 and PCI-P53-hPXR, the steps are as follows:

[0033] 1. According to the PXR and wild-type P53-AD gene sequences included in the GenBank database, design specific primers, and use PCR method to clone PXR and wild-type P53-AD gene sequences from cDNA derived from normal human primary liver cells;

[0034] 2. Through restriction endonuclease sites, the PXR and wild-type P53-AD genes were directional cloned into the eukaryotic expression vector PCI-neo (such as figure 1 shown), the recombinant eukaryotic expression vector PCI-hPXR-P53 was screened and identified by enzyme digestion, sequencing and other methods, such as figure 2 shown;

[0035] 3. Through restriction endonuclease sites, PXR and wild-type P53-AD genes were directional cloned into the eukaryotic expression vector PCI-neo (such as figure 1 shown), the recombinant eukaryotic expression vector PCI-P53-hPXR was screened and identified by enzyme ...

Embodiment 2

[0037] The dual-luciferase reporter gene system is a reporter system that uses luciferin as a substrate to detect the activity of firefly luciferase (fireflyluciferase). Luciferase can catalyze the oxidation of luciferin to oxyluciferin. During the oxidation of luciferin, it will emit bioluminescence. Combined with the co-reporter gene of marine coelenterate luciferase, when using firefly luciferase to quantify gene expression, marine cavity Enteroluciferase to reduce experimental variability. The bioluminescence released during luciferin oxidation can then be measured by a fluorometer, also known as a luminometer or a liquid scintillation meter. Luciferin and luciferase, a bioluminescent system, can detect gene expression extremely sensitively and efficiently.

[0038] A transcription factor is a protein molecule with a special structure that regulates gene expression, also known as a trans-acting factor. Some transcription factors only bind to specific sequences in their t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a chimeric gene used for improving physiologic CYP3A4 expression of human hepatocyte cultivated in vitro, and a construction method of the chimeric gene. The chimeric gene comprises a human nuclear factor pregnane X receptor gene full-length sequence and an activation-domain sequence of a wild type P53 gene. The invention further discloses a recombinant eukaryon expression vector comprising the chimeric gene. A construction method of the recombinant eukaryon expression vector comprises the following steps: cloning the human nuclear factor pregnane X receptor gene full-length sequence and the activation-domain sequence of the wild type P53 gene through cDNA from normal primary human hepatocyte; directionally cloning the two sequences obtained in the last step between Beta-globin / IgG chimeric intron sequence of a PCI-neo mammal expression vector and an SV40 Latepoly (A) signal sequence to obtain the recombinant eukaryon expression vector. The chimeric gene can remarkably improve the physiologic CYP3A4 expression of human hepatocyte cultivated in vitro.

Description

technical field [0001] The invention relates to a eukaryotic expression vector construction technology, in particular to a chimeric gene for increasing the physiological CYP3A4 expression of cultured human hepatocytes in vitro and a construction method thereof. Background technique [0002] The metabolic process of most drugs after entering the body is mainly completed by liver cells. Hepatocytes contain various enzymes involved in the biotransformation of substances in vivo and in vitro. Cytochrome P450 enzymes (CYPs, P450s) are a superfamily of monooxygenase proteins containing a hemoglobin sulfhydryl structure, and are important drug-metabolizing enzymes that complete the detoxification / bioactivation of related substrates. Among them, the CYP3A subfamily has the highest content in human liver tissue, accounting for about 30%, and is the main clinical drug-metabolizing enzyme. CYP3A4 is involved in the metabolic process of 50% of clinical drugs, and the drug metabolism s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/62C12N15/85C12N15/66
Inventor 汪艳饶小惠潘明新陈锋
Owner ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV